Clinical Trial
Influence of imipramine on the circulatory system in the course of endogenous depressive syndromes. I. Evaluation of the basic parameters of the circulatory system
- PMID: 769738
Item in Clipboard
Clinical Trial
Influence of imipramine on the circulatory system in the course of endogenous depressive syndromes. I. Evaluation of the basic parameters of the circulatory system
Arch Immunol Ther Exp (Warsz).
1975.
Abstract
In patients with endogenous depression, imipramine exerts a regulative effect in both directions on blood pressure and pulse rate, dependent on the starting levels. In a majority of patients treated with imipramine, after 14 days blood pressure dropped and pulse rate was slowed. Remission of endogenous depression was statistically significantly more frequent in patients treated with imipramine in whom pressure and pulse rate underwent normalization. Early appearance of these effects of imipramine in patients with endogenous depression seems to be a good prognostic index.
Similar articles
-
Influence of imipramine on the circulatory system in the course of endogenous depressive syndromes. II. Influence of imipramine on vascular reflexes.Arch Immunol Ther Exp (Warsz). 1975;23(6):803-7. Arch Immunol Ther Exp (Warsz). 1975. PMID: 1220631
-
A controlled study of single-dose administration of imipramine pamoate in endogenous depression.Curr Ther Res Clin Exp. 1973 Oct;15(10):700-6. Curr Ther Res Clin Exp. 1973. PMID: 4201314 Clinical Trial. No abstract available.
-
The influence of trazodone on the circulatory system in patients with endogenous depression. I. Basic circulatory parameters.Arch Immunol Ther Exp (Warsz). 1976;24(4):459-63. Arch Immunol Ther Exp (Warsz). 1976. PMID: 999460
-
[Tests on the vegetative dynamics of depression under thymoleptic treatment].Psychiatr Neurol Med Psychol Beih. 1975;20-21:99-104. Psychiatr Neurol Med Psychol Beih. 1975. PMID: 22889 German.
-
Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.Pharmacopsychiatry. 2004 Jan;37(1):18-25. doi: 10.1055/s-2004-815470. Pharmacopsychiatry. 2004. PMID: 14750044 Clinical Trial.